Small Molecule : Kinase Inhibitors. ^{(227 Clinical Stage Companies)}

Small Molecule : Proteolysis Targeting Chimera (PROTACs). ^{(22 Clinical Stage Companies)}

Nanoparticles/Nanotechnology based Cancer Targeting Drugs. ^{(42 Clinical Stage Companies)}

Cellular Therapy: T Cell/CAR-T/CAR-NK & other Cell based Therapies. ^{(168 Clinical Stage Companies)}

Oncolytic Viruses pipeline in Early Stage Development. ^{(51 Clinical Stage Companies)}

Monoclonal Antibodies pipeline in Early Stage Development. ^{(176 Clinical Stage Companies)}

Bi-Specific & Multi Specific Antibodies pipeline in Early Stage Development.^{(78 Clinical Stage Companies)}

Antibody Drug Conjugates pipeline in Early Stage Development. ^{(64 Clinical Stage Companies)}

Cancer Vaccines pipeline in Early Stage Development. ^{(121 Clinical Stage Companies)}

Microbiome based Cancer Targeting Drugs. ^{(10 Clinical Stage Companies)}